Mingshan Xue Selected Research

Mingshan Xue Research Topics

Disease

16	COVID-19 08/2023 - 09/2020
6	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022 - 02/2020
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2019
5	Inflammation (Inflammations) 11/2023 - 09/2020
4	Infections 02/2024 - 01/2022
4	Disease Progression 11/2023 - 12/2020
4	Asthma (Bronchial Asthma) 11/2021 - 01/2019
3	Pneumonia (Pneumonitis) 11/2023 - 01/2019
3	Epilepsy (Aura) 01/2023 - 01/2017
2	Hyperglycemia 01/2023 - 11/2021
2	Idiopathic Pulmonary Fibrosis 11/2022 - 01/2022
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
2	AIDS-Related Complex (ARC) 11/2021 - 01/2020
2	Lung Injury 09/2020 - 02/2020
2	Body Weight (Weight, Body) 01/2020 - 01/2020
2	Obesity 01/2020 - 01/2020
2	Neurodevelopmental Disorders 01/2020 - 11/2010
2	Schizophrenia (Dementia Praecox) 01/2017 - 11/2010
2	Autistic Disorder (Autism) 01/2017 - 11/2010
1	Hypersensitivity (Allergy) 03/2023
1	Cytokine Release Syndrome 02/2023
1	Virus Diseases (Viral Diseases) 02/2023
1	Hydrocephalus (Hydrocephaly) 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Quadriplegia (Spastic Quadriplegia) 01/2023
1	Angelman Syndrome (Syndrome, Angelman) 01/2023
1	Megalencephaly 01/2023
1	Fibrosis (Cirrhosis) 10/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Long QT Syndrome 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Channelopathies 01/2022
1	Lung Diseases (Lung Disease) 11/2021
1	Heart Failure 11/2021
1	Allergic Rhinitis 09/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2019
7	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2004
4	AcidsIBA 11/2023 - 08/2020
4	AntibodiesIBA 02/2023 - 02/2021
4	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
4	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 09/2021 - 01/2019
3	Arachidonic Acid (Vitamin F)IBA 11/2023 - 09/2021
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2023 - 01/2020
3	Neutralizing AntibodiesIBA 02/2023 - 01/2022
3	VaccinesIBA 01/2023 - 08/2021
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
3	Therapeutic UsesIBA 11/2021 - 01/2020
2	LipidsIBA 11/2023 - 08/2020
2	Hydroxyeicosatetraenoic Acids (HETE)IBA 11/2023 - 11/2021
2	Inactivated VaccinesIBA 01/2023 - 01/2022
2	Matrix Metalloproteinases (MMPs)IBA 11/2022 - 01/2020
2	Oxygen (Dioxygen)IBA 10/2022 - 01/2021
2	human AZU1 proteinIBA 10/2022 - 01/2021
2	EicosanoidsIBA 11/2021 - 01/2019
2	LeptinIBA 11/2021 - 01/2020
2	Lipoxygenase (Lipoxygenase-1)IBA 11/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2020
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 11/2010
1	Hemostatics (Antihemorrhagics)IBA 02/2024
1	Particulate MatterIBA 01/2024
1	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2023
1	KynurenineIBA 11/2023
1	Tryptophan (L-Tryptophan)FDA Link 11/2023
1	Eicosapentaenoic AcidIBA 11/2023
1	Docosahexaenoic AcidsIBA 11/2023
1	docosapentaenoic acidIBA 11/2023
1	Interferon Type IIBA 08/2023
1	AllergensIBA 03/2023
1	Antiviral Agents (Antivirals)IBA 02/2023
1	EpitopesIBA 02/2023
1	AutoantibodiesIBA 02/2023
1	Broadly Neutralizing AntibodiesIBA 02/2023
1	Antisense OligonucleotidesIBA 01/2023
1	AnoctaminsIBA 01/2023
1	AngiotensinogenIBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	CeramidesIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	SphingomyelinsIBA 01/2023
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2023
1	COVID-19 VaccinesIBA 11/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	PotassiumIBA 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Glutathione PeroxidaseIBA 11/2021
1	EnzymesIBA 11/2021
1	Environmental BiomarkersIBA 11/2021
1	Dermatophagoides farinae antigen f 1IBA 09/2021
1	Dust (House Dust)FDA Link 02/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 02/2021
1	Nucleic AcidsIBA 02/2021
1	GoldIBA 01/2021
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 01/2021

Therapy/Procedure

3	Therapeutics 02/2023 - 12/2020
3	Immunotherapy 02/2023 - 09/2021